Andrographis recall: Cold and flu medicine recalled after allergic reaction spike

Key points

• Cold and flu medicines containing andrographis have been recalled across Australia after the herb was linked to rising cases of anaphylaxis. The Therapeutic Goods Administration says these products will no longer be listed as low-risk.
• It reported a fatal case in June 2024. Several brands, including BioCeuticals Armaforce and Clinical ImmuneForce, are affected.
• The regulator has warned it will take action against retailers that have not removed the products from mid-October.